NASDAQ:JAZZ

Jazz Pharmaceuticals Stock Insider Trading

Healthcare > Biotechnology

Buy JAZZ

*Your capital is at risk

$252.86

-5.52 (-2.14%)

At Close: Jul 31, 2026

Jazz Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -67.76. In total, the insiders bought 491.67K and sold 291.63K JAZZ shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-67.76
● Buy	491.67K shares
● Sell	291.63K shares
40% Buy Activity Negligible or No Correlation
Sell Signal Medium Confidence Feb 26, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -67.76. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 05, 2026 Sell	Ordinary Shares F-InKind	Carr Patricia SVP, Chief Accounting Officer	Officer	1 436 Value: $268.2K
Mar 05, 2026 Sell	Ordinary Shares F-InKind	Pearce Samantha EVP, Chief Commercial Officer	Officer	2 503 Value: $472.3K
Mar 05, 2026 Sell	Ordinary Shares F-InKind	Johnson Philip L EVP & Chief Financial Officer	C-Suite Officer	2 615 Value: $493.4K
Mar 05, 2026 Sell	Ordinary Shares F-InKind	Cozadd Bruce C Director	Director	15 114 Value: $2.85M
Mar 05, 2026 Sell	Ordinary Shares F-InKind	Henderson Mary Elizabeth SVP, Technical Operations	Officer	1 394 Value: $260.3K
Mar 05, 2026 Sell	Ordinary Shares F-InKind	Iannone Robert EVP, Global Head Of R&d & Cmo	Officer	6 209 Value: $1.17M
Mar 05, 2026 Sell	Ordinary Shares F-InKind	Patil Neena M EVP & Chief Legal Officer	Officer	5 000 Value: $943.5K
Mar 03, 2026 Sell	Ordinary Shares S-Sale	Cozadd Bruce C Director	Director	2 608 Value: $487.0K
Mar 03, 2026 Sell	Ordinary Shares S-Sale	Cozadd Bruce C Director	Director	3 159 Value: $587.8K
Mar 03, 2026 Sell	Ordinary Shares S-Sale	Cozadd Bruce C Director	Director	233 Value: $43.8K
Feb 27, 2026 Buy	Non-Qualified Stock Option (right to buy) M-Exempt	Riedel Norbert G Director	Director	3 415 Value: $471.5K
Feb 27, 2026 Buy	Ordinary Shares M-Exempt	Riedel Norbert G Director	Director	3 415 Value: $471.5K
Feb 27, 2026 Sell	Ordinary Shares S-Sale	Riedel Norbert G Director	Director	3 415 Value: $655.7K
Feb 27, 2026 Sell	Ordinary Shares S-Sale	Carr Patricia SVP, Chief Accounting Officer	Officer	1 117 Value: $213.2K
Feb 26, 2026 Sell	Ordinary Shares S-Sale	Henderson Mary Elizabeth SVP, Technical Operations	Officer	5 343 Value: $1.04M
Feb 26, 2026 Buy	Incentive Stock Option (right to buy) M-Exempt	Patil Neena M EVP & Chief Legal Officer	Officer	2 916 Value: $399.8K
Feb 26, 2026 Buy	Non-Qualified Stock Option (right to buy) M-Exempt	Patil Neena M EVP & Chief Legal Officer	Officer	20 125 Value: $2.28M
Feb 26, 2026 Buy	Non-Qualified Stock Option (right to buy) M-Exempt	Patil Neena M EVP & Chief Legal Officer	Officer	27 084 Value: $3.71M
Feb 26, 2026 Sell	Ordinary Shares S-Sale	Patil Neena M EVP & Chief Legal Officer	Officer	16 602 Value: $3.20M
Feb 26, 2026 Buy	Ordinary Shares M-Exempt	Patil Neena M EVP & Chief Legal Officer	Officer	875 Value: $99.0K
Feb 26, 2026 Sell	Ordinary Shares S-Sale	Patil Neena M EVP & Chief Legal Officer	Officer	1 009 Value: $194.5K
Feb 26, 2026 Sell	Ordinary Shares S-Sale	Patil Neena M EVP & Chief Legal Officer	Officer	1 784 Value: $342.3K
Feb 26, 2026 Sell	Ordinary Shares S-Sale	Patil Neena M EVP & Chief Legal Officer	Officer	549 Value: $104.7K
Feb 26, 2026 Sell	Ordinary Shares S-Sale	Patil Neena M EVP & Chief Legal Officer	Officer	3 523 Value: $682.0K
Feb 26, 2026 Sell	Ordinary Shares S-Sale	Patil Neena M EVP & Chief Legal Officer	Officer	15 555 Value: $2.96M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT JAZZ PHARMACEUTICALS PLC

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. Its lead marketed products include ...

Read Full Profile Here